Peptide therapy TikTok claims: what the science actually supports

What did @boenglish actually say?

The creator pitched Selank as a Russian-developed peptide, approved in Russia in 2009 for anxiety, that works through opioid and GABA receptors while boosting dopamine and serotonin and lowering cortisol. They described it as having "almost no addictive side effects profile" and noted it's available in the U.S. through compounding pharmacies and some physicians. The framing was measured, which is more than you can say for most peptide content on this platform.

To be fair, the creator didn't make wild efficacy claims. They didn't say Selank cures anxiety disorders or that it works better than SSRIs. They suggested viewers consult a doctor, specifically a functional medicine physician or peptide specialist. That's a reasonable call to action given the regulatory reality in the U.S.

Does the science back this up?

Partially, but the evidence base is thin and almost entirely Russian. That's not automatically a disqualifier, but it matters for how confidently you should repeat these claims.

Selank is a synthetic heptapeptide derived from tuftsin, an endogenous immunomodulatory peptide. Research out of the Russian Academy of Sciences, particularly work by Seredenin and Voronina published through the 2000s and 2010s, does document anxiolytic effects in rodent models. A 2014 study by Kasian et al. in the journal Zhurnal Nevrologii i Psikhiatrii found Selank comparable to phenibut for anxiety reduction in a small clinical cohort. The GABA-modulating effects have some mechanistic support, but calling its binding to opioid receptors a primary mechanism oversimplifies what is actually a complex, incompletely understood profile. The cortisol-lowering claim has animal-model backing but no robust human RCT data.

What did they get wrong (or right)?

The mechanism description is where things get sloppy. The creator says Selank "binds to the opioid receptors and the GABA receptors" as if this is settled pharmacology. It isn't. Selank's interaction with the opioid system is suggested by some preclinical work, but characterizing it as a receptor-binding mechanism at the same level of confidence as, say, methadone and mu-opioid receptors is misleading.

The claim that it "makes more dopamine and serotonin available" is a simplified gloss on studies showing modulation of monoamine neurotransmitter metabolism, not straightforward reuptake inhibition or release. It's a different mechanism than SSRIs, yes, but the creator's explanation conflates several distinct processes.

What they got right: the 2009 Russian approval is accurate. The "almost no addictive profile" characterization is supported by existing literature, though long-term human data is essentially nonexistent. The description of U.S. availability through 503B compounding pharmacies is accurate and appropriately caveated.

What should you actually know?

Selank is one of the more interesting peptides in this space precisely because it isn't trying to be a stimulant or a growth hormone secretagogue. The anxiolytic angle, if it holds up in larger trials, could matter. But "if it holds up" is doing a lot of work in that sentence.

There are no large, double-blind, placebo-controlled trials of Selank in Western peer-reviewed journals. The existing evidence comes largely from Russian institutional research, which isn't worthless, but hasn't been independently replicated at scale. That gap should make you skeptical of confident claims about mechanism or efficacy.

If you're managing clinical anxiety or depression, this is not a substitute for working with a licensed mental health provider and considering evidence-based treatments. Selank may be worth a conversation with a physician who understands peptides, but that conversation should start with your existing diagnosis and treatment history, not a TikTok recommendation.

Where does this leave you?

The creator gave you a reasonable overview with some mechanistic overreach. Selank isn't vaporware. There's real institutional research behind it. But the gap between "approved in Russia" and "you should get some" is large enough to matter. Russia's approval process and the FDA's are not equivalent, and compounded Selank in the U.S. has not gone through the same evaluation as the Russian formulation. That doesn't mean it's dangerous. It means you're operating with incomplete information, and you should know that going in.